Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antacids Market

Antacids Market Trends

  • Report ID: GMI9703
  • Published Date: May 2024
  • Report Format: PDF

Antacids Market Trends

In the dynamic realm of gastrointestinal health management, the integration of dietary and lifestyle modifications alongside the use of antacids emerges as a pivotal strategy for achieving comprehensive symptom relief and long-term wellness. As individuals increasingly seek holistic approaches to address digestive discomfort and optimize overall health, the synergy between dietary adjustments, lifestyle changes, and pharmacological interventions becomes ever more significant.
 

  • Dietary and lifestyle changes can complement the use of antacids by addressing underlying factors contributing to gastrointestinal symptoms. For example, avoiding trigger foods such as spicy or acidic items, reducing alcohol and caffeine consumption, and adopting healthier eating habits can help minimize the frequency and severity of symptoms.
     
  • Incorporating dietary and lifestyle changes can reduce the need for frequent or prolonged use of antacids, minimizing the risk of potential side effects associated with medication use. This can lead to cost savings for consumers and healthcare systems and promote overall well-being by emphasizing natural approaches to health management.
     
  • When combined with antacid therapy, dietary and lifestyle modifications can enhance the effectiveness of treatment. Avoiding large meals before bedtime can help prevent nocturnal reflux, while maintaining a healthy weight can reduce abdominal pressure and lower the risk of gastroesophageal reflux disease (GERD) symptoms, thereby increasing the growth of the market.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global antacids industry size was valued at USD 7.1 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032 due to rising prevalence of gastrointestinal disorders and increasing pharmaceutical advancements.

The tablets segment of the market is forecasted to reach USD 6.4 billion by 2032 as they are compact and lightweight, easy to swallow, and convenient dosage form for antacids, providing a standardized and easily measurable dose of medication.

The hospital pharmacy segment of the market accounted for USD 2.2 billion in 2023 as they provide tailored antacid treatments and urgent care for gastrointestinal issues, enhancing patient outcomes and driving market growth through specialized medication management.

Aurobindo Pharma Limited, Bayer AG, Bristol Myers Squibb Company, Cipla Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gsk plc, Hikma Pharmaceuticals PLC, and Lupin Limited, among others.

Antacids Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 353
  • Countries covered: 23
  • Pages: 281
 Download Free Sample